Page 5 - Torrent Pharma

Sensex, Nifty end flat post lackluster trade; Syrma soars 42%, Titan 3%

CLOSING BELL: It was a range-bound trade on the bourses on Friday as investors awaited US Fed chief Jerome Powell's address at the Jackson Hole Symposium later tonight

Stocks to watch: Titan, Dr Reddy's, Nelco, IOC, GIC Housing, Torrent Pharma

Stocks to watch today: Titan plans to add 20 to 30 Tanishq stores over two to three years in the Middle East and North America; Nelco inked pact with Intelsat to provide inflight connectivity services

Rise of cosmetic dermatology space gets big pharma looking for buyouts

According to reports, Torrent Pharmaceuticals is set to sign a deal to acquire Curatio Healthcare, a maker of skincare products, for Rs 2100 crore.

Ceat, Ambuja, IRCTC among 30 stocks that can defy current market volatility

Ambuja Cements, Ceat, Eicher Motors, Pidilite Industries, Tata Chemicals, Torrent Power and Wockhardt are few of the prominent stocks holding on to the bullish outlook.

Torrent group rolls out succession plan; Aman Mehta joins pharma unit board

Last year, Aman had told Business Standard that they were still quite flexible to take up roles within the organisation

Torrent Pharma expected to enter diagnostics space in next 2-3 months

A company called Torrent Diagnostics Private Ltd was incorporated in February this year and has a Torrent Pharmaceuticals executive director as one of its directors

Nifty can target 16,650 in the short-term, says Vinay Rajani

The technical analyst from HDFC Securities also recommends buying CCL Products and Torrent Pharma.

Strong domestic outlook remains key growth driver for Torrent Pharma

Cost savings could drive Torrent Pharma's margins higher in the near term

Torrent Pharma's domestic show remains strong, brokerages turn positive

Progress on US sales will be key for further Torrent Pharma's stock gains

Stocks to Watch: RIL, HUL, Dr.Reddy's, PNB Housing, Future Retail, Banks

Reliance Industries is likely to be in limelight as the company is looking to take advantage of the surging diesel demand in Europe in the backdrop of Russia-Ukraine conflict.

Sensex slips 581 pts amid hawkish US Fed, F&O expiry; Nifty holds 17,100

Sectorally, the Nifty PSU Bank index jumped a massive 5 per cent on the NSE, while the Nifty Bank and Private Bank indices added about a per cent each

Torrent Pharma tumbles 14% on disappointing Q3 results

In Q3FY22, earnings before interest tax and depreciation and amortization (EBITDA) margins declined 490 bps YoY to 25.5 per cent driven by price erosion in the US.

Torrent Pharma net profit drops 16% to Rs 249 crore in third quarter

The company's revenue from operations in the third quarter stood at Rs 2,108 crore as compared to Rs 1,995 crore in the same period of previous fiscal

Sensex snaps 5-day losing run, ends 367 pts up; Nifty holds 17,250

Bargain buying in banking and auto counters amid better-than-expected Q3 results by Axis Bank and Maruti Suzuki pushed the index 367 points higher at 57,858 level at close

Pharma shares trade firm; Laurus up 2%, Sun Pharma nears 52-week high

Sun Pharma, Cipla, Natco, Dr Reddy's, Torrent Pharma, Aurobindo Pharma and Strides have launched a generic version of Molnupiravir in India post approval for emergency use authorisation from DCGI

Torrent Pharma Q2 PAT up just 2% to Rs 316 cr on drop in US sales

Overall revenues up 6% YoY, while those in US dropped by as much as 13%

Torrent Pharma gains 3% in a weak market on healthy margins in June quarter

The company has launched baricitinib during the quarter and is currently conducting clinical trials for molnupiravir; more partnerships under evaluation to widen Covid portfolio

Torrent Pharma Q1 net grows marginally by 3% as price erosion in US weighs

The company's revenues also grew in single digits at four per cent, from Rs 2,056 crore in Q1 of FY21 to Rs 2,134 crore in Q1 of FY22

NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine

These are scheduled drugs (or ones that are under price control) and low priced

Cipla, Dr Reddy's Labs: Tech charts show up to 11% upside in pharma stocks

After hitting a new all-time high of Rs 997 earlier today, the stock of Cipla is all set to rally towards Rs 1,100